You are here

The Progress Report Progress never stops. Stay informed with the latest news on breast cancer research, treatment, and prevention.

Tag:

AACR x

a healthy salad with weights and a tape measure to illustrate healthy lifestyle

At this year’s American Association for Cancer Research (AACR) annual meeting, held virtually last month, several studies presented sought to tease apart the relationships between obesity, inflammation, metabolic factors, and breast cancer.

a female scientist wearing a lab coat and mask analyzes samples

At the 112th American Association of Cancer Research (AACR) annual meeting, held virtually in April, more than 13,500 attendees joined to hear their colleagues present and share information on cutting-edge advances in basic, clinical, and translational cancer research.

Test tubes in a research lab

The annual American Association for Cancer Research (AACR) meeting is the largest international cancer conference, attracting more than 25,000 participants every spring.

Tags:

On April 14-18, more than 21,000 cancer scientists, survivors and advocates gathered at the annual meeting of the American Association for Cancer Research.

Tags:

Research conferences are great opportunities to present new and emerging ideas, and the 2017 AACR Annual Meeting was no exception.

During the opening ceremony of its annual meeting, the American Association of Cancer Research (AACR) presented BCRF investigator, Dr.

This post was written by Margaret Flowers PhD, Associate Director, Grants Program and Scientific Communications of BCRF

Tags:

The AACR annual meetings typically conclude with a final plenary session focused on highlights from the meeting and visions for the future in cancer research. This year’s final plenary session in New Orleans was augmented by a very special presentation from Vice President Biden. Mr.

It’s been an exciting week at AACR. Here are a few highlights from clinical trials in breast cancer reported at Monday’s session.

 

​​A Presurgery Combination Therapy May Improve Outcomes for Women With HER2-positive Breast Cancer